Neil Almstead's most recent trade in PTC Therapeutics Inc was a trade of 2,464 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2026 | 2,464 | 45,036 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.54 per share. | 09 Jul 2026 | 2,464 | 62,763 (0%) | 0% | 46.5 | 114,675 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 90.25 per share. | 09 Jul 2026 | 2,464 | 60,299 (0%) | 0% | 90.3 | 222,376 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 24,613 | 9,063 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.42 per share. | 06 Jul 2026 | 24,613 | 84,912 (0%) | 0% | 39.4 | 970,244 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 06 Jul 2026 | 18,876 | 79,175 (0%) | 0% | 38.1 | 719,176 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 18,876 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 89.03 per share. | 06 Jul 2026 | 11,369 | 69,587 (0%) | 0% | 89.0 | 1,012,182 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 86.32 per share. | 06 Jul 2026 | 10,090 | 60,299 (0%) | 0% | 86.3 | 870,969 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 89.44 per share. | 06 Jul 2026 | 9,288 | 60,299 (0%) | 0% | 89.4 | 830,719 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.35 per share. | 06 Jul 2026 | 8,786 | 70,389 (0%) | 0% | 85.3 | 749,885 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 87.17 per share. | 06 Jul 2026 | 3,956 | 80,956 (0%) | 0% | 87.2 | 344,845 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 2,474 | 33,676 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 87.03 per share. | 06 Jul 2026 | 2,474 | 60,299 (0%) | 0% | 87.0 | 215,312 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.42 per share. | 06 Jul 2026 | 2,474 | 62,773 (0%) | 0% | 39.4 | 97,525 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 06 Jul 2026 | 811 | 61,110 (0%) | 0% | 38.1 | 30,899 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 811 | 18,876 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.28 per share. | 06 Jul 2026 | 426 | 60,684 (0%) | 0% | 85.3 | 36,329 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 86.34 per share. | 06 Jul 2026 | 385 | 60,299 (0%) | 0% | 86.3 | 33,241 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2026 | 7,718 | 19,687 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.26 per share. | 26 Jun 2026 | 7,718 | 60,137 (0%) | 0% | 85.3 | 658,037 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 26 Jun 2026 | 7,718 | 67,855 (0%) | 0% | 38.1 | 294,056 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 26 Jun 2026 | 412 | 60,549 (0%) | 0% | 38.1 | 15,697 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2026 | 412 | 27,405 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.23 per share. | 26 Jun 2026 | 412 | 60,137 (0%) | 0% | 85.2 | 35,115 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 19,859 | 27,817 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 24 Jun 2026 | 19,859 | 79,996 (0%) | 0% | 38.1 | 756,628 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 86.51 per share. | 24 Jun 2026 | 11,337 | 60,137 (0%) | 0% | 86.5 | 980,764 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.26 per share. | 24 Jun 2026 | 8,522 | 71,474 (0%) | 0% | 85.3 | 726,586 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 4,922 | 48,677 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.03 per share. | 24 Jun 2026 | 4,922 | 60,137 (0%) | 0% | 85.0 | 418,518 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 24 Jun 2026 | 4,922 | 65,059 (0%) | 0% | 38.1 | 187,528 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 1,001 | 47,676 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 24 Jun 2026 | 1,001 | 61,138 (0%) | 0% | 38.1 | 38,138 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.24 per share. | 24 Jun 2026 | 582 | 60,556 (0%) | 0% | 85.2 | 49,610 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 86.39 per share. | 24 Jun 2026 | 419 | 60,137 (0%) | 0% | 86.4 | 36,197 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.10 per share. | 24 Jun 2026 | 401 | 60,538 (0%) | 0% | 38.1 | 15,278 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 401 | 53,599 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.01 per share. | 24 Jun 2026 | 401 | 60,137 (0%) | 0% | 85.0 | 34,089 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2026 | 100 | 36,150 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 87.00 per share. | 24 Jun 2026 | 100 | 60,137 (0%) | 0% | 87 | 8,700 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.42 per share. | 24 Jun 2026 | 100 | 60,237 (0%) | 0% | 39.4 | 3,942 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.69 per share. | 22 Jun 2026 | 23,749 | 83,886 (0%) | 0% | 25.7 | 610,112 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2026 | 23,749 | 23,751 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.61 per share. | 22 Jun 2026 | 12,130 | 71,756 (0%) | 0% | 80.6 | 977,799 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 81.21 per share. | 22 Jun 2026 | 11,619 | 60,137 (0%) | 0% | 81.2 | 943,579 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 68.89 per share. | 01 Apr 2026 | 39,393 | 72,747 (0%) | 0% | 68.9 | 2,713,784 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 69.50 per share. | 01 Apr 2026 | 12,530 | 60,217 (0%) | 0% | 69.5 | 870,835 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 70.30 per share. | 01 Apr 2026 | 80 | 60,137 (0%) | 0% | 70.3 | 5,624 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 63.38 per share. | 05 Mar 2026 | 3,989 | 2,737 (0%) | 0% | 63.4 | 252,823 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 69.36 per share. | 18 Feb 2026 | 3,056 | 112,140 (0%) | 0% | 69.4 | 211,964 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 69.35 per share. | 18 Feb 2026 | 65 | 6,726 (0%) | 0% | 69.4 | 4,508 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.45 per share. | 08 Jan 2026 | 881 | 115,196 (0%) | 0% | 76.4 | 67,352 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.46 per share. | 08 Jan 2026 | 59 | 6,791 (0%) | 0% | 76.5 | 4,511 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.95 per share. | 06 Jan 2026 | 1,279 | 117,103 (0%) | 0% | 76.9 | 98,419 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 77.48 per share. | 06 Jan 2026 | 1,026 | 116,077 (0%) | 0% | 77.5 | 79,494 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 76.94 per share. | 06 Jan 2026 | 54 | 6,902 (0%) | 0% | 76.9 | 4,155 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 77.48 per share. | 06 Jan 2026 | 52 | 6,850 (0%) | 0% | 77.5 | 4,029 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 43,750 | 43,750 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 17,500 | 118,382 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 520 | 6,956 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 25 Nov 2025 | 47,624 | 148,249 (0%) | 0% | 33.0 | 1,572,544 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 47,624 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.33 per share. | 25 Nov 2025 | 21,844 | 112,891 (0%) | 0% | 83.3 | 1,820,261 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.55 per share. | 25 Nov 2025 | 13,514 | 134,735 (0%) | 0% | 82.6 | 1,115,581 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 11,399 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 25 Nov 2025 | 11,399 | 112,024 (0%) | 0% | 33.0 | 376,395 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.42 per share. | 25 Nov 2025 | 9,171 | 103,720 (0%) | 0% | 84.4 | 774,216 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 8,410 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 25 Nov 2025 | 8,410 | 109,035 (0%) | 0% | 18.0 | 151,464 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.39 per share. | 25 Nov 2025 | 4,834 | 103,446 (0%) | 0% | 83.4 | 403,107 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.61 per share. | 25 Nov 2025 | 3,744 | 108,280 (0%) | 0% | 82.6 | 309,292 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.41 per share. | 25 Nov 2025 | 3,663 | 102,582 (0%) | 0% | 83.4 | 305,531 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.15 per share. | 25 Nov 2025 | 3,095 | 100,625 (0%) | 0% | 85.1 | 263,539 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.82 per share. | 25 Nov 2025 | 2,790 | 106,245 (0%) | 0% | 82.8 | 231,068 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.54 per share. | 25 Nov 2025 | 2,621 | 100,825 (0%) | 0% | 84.5 | 221,579 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 2,475 | 8,410 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 25 Nov 2025 | 2,475 | 103,100 (0%) | 0% | 18.0 | 44,575 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2025 | 2,020 | 47,624 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 25 Nov 2025 | 2,020 | 102,645 (0%) | 0% | 33.0 | 66,700 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.56 per share. | 25 Nov 2025 | 1,757 | 100,825 (0%) | 0% | 84.6 | 148,572 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.44 per share. | 25 Nov 2025 | 990 | 101,199 (0%) | 0% | 83.4 | 82,606 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.63 per share. | 25 Nov 2025 | 911 | 102,189 (0%) | 0% | 82.6 | 75,276 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 83.35 per share. | 25 Nov 2025 | 862 | 101,094 (0%) | 0% | 83.4 | 71,848 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 82.63 per share. | 25 Nov 2025 | 689 | 101,956 (0%) | 0% | 82.6 | 56,932 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.67 per share. | 25 Nov 2025 | 574 | 100,625 (0%) | 0% | 84.7 | 48,601 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 84.61 per share. | 25 Nov 2025 | 289 | 100,805 (0%) | 0% | 84.6 | 24,452 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.34 per share. | 25 Nov 2025 | 200 | 100,625 (0%) | 0% | 85.3 | 17,068 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.37 per share. | 25 Nov 2025 | 200 | 100,625 (0%) | 0% | 85.4 | 17,074 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 85.17 per share. | 25 Nov 2025 | 180 | 100,625 (0%) | 0% | 85.2 | 15,331 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 21,206 | 49,644 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.19 per share. | 24 Nov 2025 | 21,206 | 100,625 (0%) | 0% | 80.2 | 1,700,509 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 24 Nov 2025 | 21,206 | 121,831 (0%) | 0% | 33.0 | 700,222 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.17 per share. | 24 Nov 2025 | 6,101 | 100,625 (0%) | 0% | 80.2 | 489,117 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.02 per share. | 24 Nov 2025 | 6,101 | 106,726 (0%) | 0% | 33.0 | 201,455 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 6,101 | 11,399 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 4,715 | 10,885 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Sale of securities on an exchange or to another person at price $ 80.15 per share. | 24 Nov 2025 | 4,715 | 100,625 (0%) | 0% | 80.1 | 377,907 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 24 Nov 2025 | 4,715 | 105,340 (0%) | 0% | 18.0 | 84,917 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 24 Nov 2025 | 1,900 | 102,525 (0%) | 0% | 18.0 | 34,219 | Common Stock |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2025 | 1,900 | 15,600 | - | - | Stock Option (Right to Buy) |